India, March 3 -- The book is written in a very conversational manner - like the best-researched Instagram caption in the world! Why did you avoid opting for a more academic tone? That's how I speak!... Read More
France, March 3 -- Iran's soccer chief Mehdi Taj said he and senior government officials would assess whether the squad should take part in the competition, which begins on 11 June. "It's not possibl... Read More
Srinagar, March 3 -- The Jammu & Kashmir National Conference Chief Spokesperson Tanvir Sadiq Tuesday appealed to the Union Home Minister and the Lieutenant Governor to consider releasing the youths wh... Read More
U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07441785) titled 'Immediate and Functional Results of Different Types of Reconstructions After Proximal Gastr... Read More
U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07444034) titled 'A Pilot Study of a Portable Head-Only MRI Scanner' on Feb. 24. Brief Summary: This is a pi... Read More
U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07443280) titled 'Alterations of Gut Derived Uremic Toxins and Microbiome Metabolites by Multispecies Synbiot... Read More
U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07442942) titled 'Effect of Exercise of Shoulder - Pelvic Coupling Pattern on Breathing Using Proprioceptive ... Read More
U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07443007) titled 'Effects of Balance, Plyometric, and Combined Plyometric-Balance Training in Pediatric Burn ... Read More
U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07442929) titled 'Crystallization of LA and Adjuvant Mixtures in Cerebrospinal Fluid' on Sept. 18, 2025. Bri... Read More
U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07441395) titled 'Phase 2 Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD' on Feb. ... Read More